管理提醒： 本帖被 gjzh195820 从 外文期刊互助 移动到本区(2016-11-21)
【作者】Gravis G1, Boher JM2, Joly F3, Soulié M4, Albiges L5, Priou F6, Latorzeff I7, Delva R8, Krakowski I9, Laguerre B10, Rolland F11, Théodore C12, Deplanque G13, Ferrero JM14, Culine S15, Mourey L16, Beuzeboc P17, Habibian M18, Oudard S19, Fizazi K5; GETUG.
【文章标题】Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival ysis of the Randomized Phase 3 GETUG-AFU15 Trial.
【期刊名，年份，卷（期），起止页*****】Eur Urol. 2016 Aug;70(2):256-62. doi: 10.1016/j.eururo.2015.11.005. Epub 2015 Nov 21.
【全文链接】
http://linkinghub.elsevier.com/retrieve/pii/S0302-2838(15)01103-3
